指南与共识慢性肾脏病水电解质与酸碱

慢性肾脏病新型贫血治疗:KDIGO争议会议结论

Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
指南 / 共识 · Kidney Int · 2023-05-24

贫血在慢性肾脏病患者中常见,与高疾病负担和不良临床结局相关。2012年KDIGO发布了慢性肾脏病贫血诊治指南,此后出现了评估现有和新兴贫血及缺铁治疗的新数据。KDIGO计划了两次争议会议以审查新证据,本文报告2021年12月虚拟举行的第二次会议,聚焦缺氧诱导因子脯氨酰羟化酶抑制剂(HIF-PHI)这一新药类别,提供共识要点与争议的综述,并强调未来研究需优先关注的领域。

要点

  • 贫血在慢性肾脏病患者中常见,与高疾病负担和不良临床结局相关。
  • 2012年KDIGO发布了慢性肾脏病贫血诊治指南,此后出现评估现有和新兴治疗的新数据。
  • 第二次KDIGO争议会议于2021年12月虚拟举行,聚焦HIF-PHI,提供共识要点与争议综述。

核心结论

  • 本文报告了第二次KDIGO争议会议的共识要点与争议,并强调未来研究需优先关注的领域。

研究设计与样本

  • KDIGO计划了两次争议会议以审查新证据及其对临床实践的影响,本文报告第二次会议,于2021年12月虚拟举行,聚焦HIF-PHI。

主要发现

  • 自2012年KDIGO贫血指南发布后,出现了评估现有和新兴贫血及缺铁治疗的新数据。
  • 第二次会议聚焦缺氧诱导因子脯氨酰羟化酶抑制剂(HIF-PHI)这一新药类别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anemia is common in patients with chronic kidney disease and is associated with a high burden of morbidity and adverse clinical outcomes. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) published a guideline for the diagnosis and management of anemia in chronic kidney disease. Since then, new data from studies assessing established and emerging therapies for the treatment of anemia and iron deficiency have become available. Beginning in 2019, KDIGO planned 2 Controversies Conferences to review the new evidence and its potential impact on the management of anemia in clinical practice. Here, we report on the second of these conferences held virtually in December 2021, which focused on a new class of agents-the hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs). This report provides a review of the consensus points and controversies from this second conference and highlights areas that warrant prioritization for future research.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ku E, Del Vecchio L, Eckardt KU, et al. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023. PMID: 37236424. doi:10.1016/j.kint.2023.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。